| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6720314 | DORC | Use of a vital dye for facilitating surgical procedures for cataract extraction |
May, 2019
(5 years ago) | |
| US6367480 | DORC | Methods for visualizing the anterior lens capsule of the human eye |
Oct, 2019
(4 years ago) | |
Visionblue is owned by Dorc.
Visionblue contains Trypan Blue.
Visionblue has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Visionblue are:
- US6720314
- US6367480
Visionblue was authorised for market use on 16 December, 2004.
Visionblue is available in solution;ophthalmic dosage forms.
Visionblue can be used as a method of applying trypan blue onto an outer surface of the anterior lens capsule to facilitate removal of the lens substance.
The generics of Visionblue are possible to be released after 26 October, 2019.
Drugs and Companies using TRYPAN BLUE ingredient
Market Authorisation Date: 16 December, 2004
Treatment: A method of applying trypan blue onto an outer surface of the anterior lens capsule to facilitate removal of the lens substance
Dosage: SOLUTION;OPHTHALMIC
VISIONBLUE family patents
